Garry Arthur Neil

Companies

• Avalo Therapeutics, Inc.Board member Mar 2, 2026 to now¹
• Celldex TherapeuticsBoard member Jun 17, 2022 to now²
• Avalo Therapeutics, Inc.Chief executive officer Mar 10, 2022 to now³
• Avalo Therapeutics, Inc.Chair Oct 7, 2022 to Jan 30, 2025⁴
• Zura Bio LtdBoard member Mar 21, 2023 to May 22, 2023⁵
• Arena PharmaceuticalsBoard member Feb 14, 2017 to Mar 11, 2022⁶
• Avalo Therapeutics, Inc.Chief Medical Officer Feb 5, 2020 to Dec 14, 2021⁷
• Oncternal Therapeutics, Inc.Board member Sep 1, 2016 to Jan 3, 2019⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAvalo Therapeutics, Inc. AVTX190,314 shares⁹$2.2M at $11.58May 21, 2026
• Arena Pharmaceuticals ARNA0 shares¹⁰Mar 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• May 21, 2026Granted 100,200 shares of Avalo Therapeutics, Inc.⁹
• Mar 28, 2026Shares withheld for tax 21,892 shares at $13.89 of Avalo Therapeutics, Inc.¹¹
• Mar 28, 2026Exercised options 64,866 shares of Avalo Therapeutics, Inc.¹¹
• Mar 28, 2025Shares withheld for tax 17,787 shares at $8.46 of Avalo Therapeutics, Inc.¹²
• Mar 28, 2025Exercised options 64,867 shares of Avalo Therapeutics, Inc.¹²
• Jun 9, 2023Bought 4,000 shares at $3.42 of Avalo Therapeutics, Inc.¹³
• Dec 9, 2022Bought 2,083 shares at $4.42 of Avalo Therapeutics, Inc.¹⁴
• Mar 11, 2022Other 3,067 shares of Arena Pharmaceuticals¹⁰
• Mar 11, 2022Other 8,150 shares of Arena Pharmaceuticals¹⁰
• Dec 10, 2021Bought 4,267 shares at $1.57 of Avalo Therapeutics, Inc.¹⁵